Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations.
about
The endocrine function of adipose tissue: an updateA family with complement factor D deficiencyRegulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytesAssociation of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.The complement system: a pathway linking host defence and adipocyte biology.Acylation stimulating protein, complement C3 and lipid metabolism in ketosis-prone diabetic subjects.Time-course microarrays reveal early activation of the immune transcriptome and adipokine dysregulation leads to fibrosis in visceral adipose depots during diet-induced obesity.Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?Relationship of C5L2 receptor to skeletal muscle substrate utilization.Influence of acute hyperlipidemia to adipocyte-derived hormones in lean normotensive and subjects with metabolic syndrome.Deficiency of C5L2 increases macrophage infiltration and alters adipose tissue function in mice.Effect of periodontal treatment on adipokines in type 2 diabetes.Cellulite: nature and aetiopathogenesis.Diabetes, lipids, and adipocyte secretagogues.Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics.Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis.Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese womenSerum Adipsin Levels throughout Normal Pregnancy and Preeclampsia.Regulation of postprandial lipemia: an update on current trends.Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomesElevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal womenRacial difference in Acylation Stimulating Protein (ASP) correlates to triglyceride in non-obese and obese African American and Caucasian women.Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels.Elevated fetal adipsin/acylation-stimulating protein (ASP) in obese pregnancy: novel placental secretion via Hofbauer cells.The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance.Plasma Levels of Acylation-Stimulating Protein Are Strongly Predicted by Waist/Hip Ratio and Correlate with Decreased LDL Size in Men.Low acylation stimulating protein levels are associated with cardiometabolic disorders-secondary to autoimmune activation?Association of C5L2 genetic polymorphisms with coronary artery disease in a Han population in Xinjiang, China.Acylation stimulating protein: a female lipogenic factor?LOX-1 and obesity.Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice.Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo.The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance.Intermediate and low abundant protein analysis of vitamin D deficient obese and non-obese subjects by MALDI-profiling.Targeting the signaling pathway of acylation stimulating protein.ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes.Cord lining progenitor cells: potential in vitro adipogenesis model.Genetic variation at the adipsin locus and response to long-term overfeeding.Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance.Bivariate linkage between acylation-stimulating protein and BMI and high-density lipoproteins.
P2860
Q28305131-E8F7206F-77F1-4D61-8646-BEFE13587082Q28344130-4A43895B-A217-4037-84E0-5E57F01DF030Q28365571-D115D98C-3DD7-4F96-885F-A28082EEF7FDQ30384917-ADF9A423-0566-4BD1-B34B-42498E87B081Q33717457-1C6FDB6B-C690-4C0B-AB7A-D7A030929B37Q34282344-C8DAEA01-DDA0-47BF-B330-C8FF03491CF2Q34402691-AB30C099-6E0D-406A-AEC5-44BB48F2DAF6Q34591803-B12345DD-9143-43AD-9B86-ABAB3CB6E659Q34608628-323ADFE9-795D-4466-83FE-B43C634FCC67Q34695239-C126BF20-D147-4C63-BD33-11C673FBB101Q34695413-4306870F-B5A1-476D-9196-996FF2CE2584Q34699263-F835AE39-C36A-40AB-9B13-07F8580078CCQ34779547-F069094F-74A2-4915-B77A-736F78729B9BQ35723496-46B32D1B-AEA2-4A5C-A799-3AC72E75D0C5Q35808559-95BEE11B-23B7-4C25-B0B6-273C2EA35E88Q36140527-6A93DD5E-9069-489B-8C69-7C5B0BBABCBCQ36203380-1A9BAB30-B827-4C82-8EBB-96607592AABBQ36527563-D10937EB-2854-4968-B757-E8BEC731E1C0Q36749246-017F7423-9FA1-4228-B1B1-6478D647197CQ37067258-7CEE59E6-525A-42AC-BF63-B4A201934C87Q37181325-CE74D0C5-C35E-469B-8DA9-77985DB2946EQ37184230-96C5891F-7496-48C0-A660-AEF5BEAE55EFQ37190372-951CF81F-8937-4B02-88E1-E7D1D1956CCCQ37215478-9E0B7FBE-06E5-4625-8BE1-5D90DB12A52AQ37280702-A3AB0FAC-3BF2-4A73-B4F9-3A09460DE809Q37515367-DDB4F3AC-11A6-48F1-AF27-AFE92A7B4362Q37680316-D6A2D74C-705B-4BC0-82E1-15DDC839A76DQ37702759-9AC0398E-F617-4B3F-B636-782AC97ADA67Q37846807-60045A9C-581D-4999-A0F9-0C31B2A092B8Q37924630-345A2DAB-797B-4DF8-BEDA-9B4D559A2636Q38362744-68FFCCCF-0046-4B03-8EAE-A722C29DA917Q40090989-F1B6BD9A-3E77-4596-8688-BDB05D2719ECQ40140325-F29F0E2E-BC40-403A-8D2A-4FB601EAB074Q42282520-2D44852C-FA30-4681-8452-DC72B2A1A38EQ42487513-D40A1B42-AF17-4563-8836-AA44DBF3897AQ42832707-653215F4-133E-4A34-947B-78F6413FCB39Q43060941-E935412F-E598-46AE-85EC-E6B7B7B0B7C5Q44568007-CDAD0510-1BF9-46E9-95FB-EE2141BAF013Q44620944-04B40181-E233-458D-BF55-23BE2EEE6C2DQ44848288-9B23AB54-F9D0-4B30-BAD7-B7303B4155F1
P2860
Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Plasma acylation stimulating p ...... n-obese and obese populations.
@ast
Plasma acylation stimulating p ...... n-obese and obese populations.
@en
type
label
Plasma acylation stimulating p ...... n-obese and obese populations.
@ast
Plasma acylation stimulating p ...... n-obese and obese populations.
@en
prefLabel
Plasma acylation stimulating p ...... n-obese and obese populations.
@ast
Plasma acylation stimulating p ...... n-obese and obese populations.
@en
P2093
P2860
P1476
Plasma acylation stimulating p ...... n-obese and obese populations.
@en
P2093
A D Sniderman
K Cianflone
M Maslowska
P2860
P304
P356
10.1046/J.1365-2362.1999.00514.X
P577
1999-08-01T00:00:00Z